Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401583 · ClinicalTrials.gov registry record · Phase 1
A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00401583 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 24 participants.
The verdict
NCT00401583, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a Phase I study to determine the effect of GW786034 (pazopanib) on P450 enzymes. This study will help determine which types of drugs may interact with GW786034.
Interventions
- DRUG GW786034 (pazopanib)
- DRUG Probe drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-07-28 |
| Est. Completion | 2008-02-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00401583
The ClinicalTrials.gov registry entry for NCT00401583 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GW786034 (pazopanib) is the first listed.
NCT00401583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00401583 about?
NCT00401583 is a clinical study titled "A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes". This is a Phase I study to determine the effect of GW786034 (pazopanib) on P450 enzymes. This study will help determine which types of drugs may interact with GW786034.
What is the current status of trial NCT00401583?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2006-07-28. Estimated completion is 2008-02-20.
What interventions are being tested in trial NCT00401583?
The interventions under investigation include: GW786034 (pazopanib) (DRUG), Probe drugs (DRUG).
Who is sponsoring clinical trial NCT00401583?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.